Td Waterhouse Canada Inc. Vertex Pharmaceuticals Inc Transaction History

Td Waterhouse Canada Inc.

$12.3 Trillion
Q3 2024

A detailed history of Td Waterhouse Canada Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 2,454 shares of VRTX stock, worth $1.11 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,454

Previous 965 154.3%

Holding current value

$1.11 Million

Previous $455 Million 153.3%

% of portfolio

0.01%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$460.0 - $505.78 $684,940 - $753,106	1,489 Added 154.3%	2,454 $1.15 Billion
Q2 2024 Nov 12, 2024	SELL	$392.81 - $485.53 $549,541 - $679,256	-1,399 Reduced 59.18%	965 $455 Million
Q2 2024 Aug 02, 2024	SELL	$392.81 - $485.53 $1.15 Million - $1.42 Million	-2,931 Reduced 55.35%	2,364 $1.33 Billion
Q1 2024 May 10, 2024	BUY	$407.69 - $446.08 $425,220 - $465,261	1,043 Added 24.53%	5,295 $2.18 Billion
Q4 2023 Feb 12, 2024	SELL	$343.0 - $410.68 $431,494 - $516,635	-1,258 Reduced 22.83%	4,252 $1.78 Billion
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $406,492 - $435,676	1,202 Added 27.9%	5,510 $1.99 Billion
Q2 2023 Nov 13, 2023	BUY	$314.42 - $351.91 $991,051 - $1.11 Million	3,152 Added 272.66%	4,308 $1.51 Billion
Q1 2023 Nov 13, 2023	SELL	$283.23 - $323.1 $489,704 - $558,639	-1,729 Reduced 59.93%	1,156 $369 Million
Q4 2022 Nov 13, 2023	SELL	$285.76 - $321.48 $2.36 Million - $2.65 Million	-8,258 Reduced 74.11%	2,885 $841 Million
Q3 2022 Nov 13, 2023	SELL	$273.83 - $305.53 $380,623 - $424,686	-1,390 Reduced 11.09%	11,143 $4.23 Billion
Q2 2022 Nov 13, 2023	SELL	$234.96 - $292.55 $5,169 - $6,436	-22 Reduced 0.18%	12,533 $4.56 Billion
Q1 2022 Nov 13, 2023	SELL	$221.42 - $260.97 $3.71 Million - $4.37 Million	-16,737 Reduced 57.14%	12,555 $4.11 Billion
Q4 2021 Nov 13, 2023	BUY	$177.01 - $223.45 $5.18 Million - $6.55 Million	29,292 New	29,292 $6.53 Billion

Others Institutions Holding VRTX

# of Institutions

1,728

Shares Held

223M

Call Options Held

1.65M

Put Options Held

1.38M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.

Account

Td Waterhouse Canada Inc. Vertex Pharmaceuticals Inc Transaction History